Universidad del País Vasco/Euskal Herriko Unibertsitatea-ko ikertzaileekin lankidetzan egindako argitalpenak (22)

2023

  1. Right hepatic artery pseudoaneurysm due to cholecystitis

    Cirugia Espanola, Vol. 101, Núm. 9, pp. 650-653

  2. Surgical treatment for recurrent cholangiocarcinoma: a single-center series

    Frontiers in Oncology, Vol. 13

2022

  1. Hydatid cyst with gastric fistula

    Cirugia Espanola, Vol. 100, Núm. 12, pp. 786

  2. Totally laparoscopic simultaneous resection of colorectal cancer and synchronous liver metastases: a single-center case series

    Surgical Endoscopy, Vol. 36, Núm. 2, pp. 980-987

2021

  1. Transplantation-mediated alloimmune thrombocytopenia successfully treated by retransplantation

    Lupus, Vol. 30, Núm. 4, pp. 669-673

2020

  1. Black esophagus after combined liver-kidney transplantation

    Gastroenterologia y Hepatologia, Vol. 43, Núm. 1, pp. 25-27

  2. Endovascular Therapy of Arterial Complications Within the First Week After Liver Transplant

    Transplantation Proceedings, Vol. 52, Núm. 5, pp. 1464-1467

  3. Long-Term Outcomes of Liver Transplantation in Patients With Pretransplant Renal Dysfunction Treated With Induction Therapy and Delayed Reduced De Novo Once-Daily Tacrolimus

    Transplantation Proceedings, Vol. 52, Núm. 5, pp. 1489-1492

2019

  1. Long term recurrence free survival in a stage IV gallbladder cancer treated with chemotherapy plus trastuzumab and salvage liver resection

    Annals of Hepato-Biliary-Pancreatic Surgery, Vol. 23, Núm. 4, pp. 403-407

2018

  1. Significance of measured intraoperative portal vein flows after thrombendvenectomy in deceased donor liver transplantations with portal vein thrombosis

    Liver Transplantation

2017

  1. Human immunodeficiency virus–infected liver transplant recipients with incidental hepatocellular carcinoma: A prospective multicenter nationwide cohort study

    Liver Transplantation, Vol. 23, Núm. 5, pp. 645-651

2016

  1. Erratum: Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study (Journal of Hepatology (2015) 62 (92-100))

    Journal of Hepatology

  2. Favorable longterm outcomes of liver transplant recipients treated de novo with once-daily tacrolimus: Results of a single-center cohort

    Liver Transplantation, Vol. 22, Núm. 10, pp. 1391-1400

  3. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

  4. Octogenarian Donors in Liver Transplantation

    Transplantation Proceedings, Vol. 48, Núm. 9, pp. 2856-2858

2015

  1. Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study

    Journal of Hepatology, Vol. 62, Núm. 1, pp. 92-100

2013

  1. Tacrolimus dose individualization in "de novo" patients after 10 years of experience in liver transplantation: Pharmacokinetic considerations and patient pathophysiology

    International Journal of Clinical Pharmacology and Therapeutics, Vol. 51, Núm. 7, pp. 606-614

  2. Tacrolimus pharmacokinetics in the early post-liver transplantation period and clinical applicability via Bayesian prediction

    European Journal of Clinical Pharmacology, Vol. 69, Núm. 1, pp. 65-74

2011

  1. Pathophysiological idiosyncrasies and pharmacokinetic realities may interfere with tacrolimus dose titration in liver transplantation

    European Journal of Clinical Pharmacology, Vol. 67, Núm. 7, pp. 671-679

  2. Pharmacokinetics for once-daily versus twice-daily tacrolimus formulations in de novo liver transplantation: A randomized, open-label trial

    Liver Transplantation, Vol. 17, Núm. 2, pp. 167-177